Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 31, 2026 07:32 ET | Source: Research and Markets

Ovarian Cancer Drugs Market Outlook Report 2026-2030 Featuring Strategic Analysis of AstraZeneca, Roche, Bristol-Myers Squibb Company, Clovis Oncology, Pfizer and Other Key Players

Dublin, March 31, 2026 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Drugs Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report delivers a comprehensive analysis, covering...
March 30, 2026 16:05 ET | Source: Fortress Biotech, Inc.

Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million

MIAMI, March 30, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its majority-owned subsidiary, Cyprium Therapeutics, Inc. (“Cyprium”), today announced the closing of...
March 30, 2026 16:05 ET | Source: Lexeo Therapeutics

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Lexeo Earnings release
March 30, 2026 06:35 ET | Source: Research and Markets

$1.59 Billion PD-1 Resistant Head and Neck Cancer Market Analysis Report 2026: Size, Growth, and Segmentation Insights to 2030

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "PD-1 Resistant Head and Neck Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The PD-1 resistant head and neck...
March 30, 2026 06:33 ET | Source: Research and Markets

Advanced Melanoma Markets and Companies 2026-2030: Cumulative Revenue to Grow by $1.87 Billion

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Advanced Melanoma Market Report 2026" has been added to ResearchAndMarkets.com's offering. The advanced melanoma market has demonstrated robust...
March 30, 2026 06:00 ET | Source: Research and Markets

Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Bile Duct Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The bile duct cancer market is witnessing robust...
March 30, 2026 05:51 ET | Source: Research and Markets

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Pancreatic Adenocarcinoma Treatment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The pancreatic adenocarcinoma...
March 30, 2026 05:39 ET | Source: Research and Markets

Recurrent Head and Neck Cancer Squamous Cell Carcinoma Markets and Competition Outlook 2026-2030: Personalized Medicine Drives Revenue Growth, Reaching $4.61 Billion by 2030

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers...
March 30, 2026 05:37 ET | Source: Research and Markets

Uveal Neoplasms Markets, Companies, and Investment Opportunities Analysis 2026-2030

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Uveal Neoplasms Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global uveal neoplasms market has demonstrated...
March 30, 2026 05:25 ET | Source: Research and Markets

Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow by $1 Billion During 2026-2030 - Johnson & Johnson, Janssen Research & Development, and Merck & Co. Lead the Competition

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Non-Muscle Invasive Bladder Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The non-muscle invasive bladder...